Q2 2025 Holdings
Filed 2025-08-14 | 39 holdings | $410.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $49.6M | 1,773,649 | 12.1% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $34.3M | 110,000 | 8.4% |
| Meiragtx Hldgs PLC(MGTX) | COM | G59665102 | $29.9M | 4,587,423 | 7.3% |
| ADC Therapeutics SA(ADCT) | SHS | H0036K147 | $28.1M | 10,467,771 | 6.8% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $20.4M | 472,687 | 5.0% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $20.4M | 1,808,539 | 5.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $19.9M | 3,480,044 | 4.9% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $19.7M | 853,904 | 4.8% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $18.4M | 3,181,184 | 4.5% |
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $16.4M | 1,309,904 | 4.0% |
| Icon PLC(ICLR) | SHS | G4705A100 | $14.3M | 98,558 | 3.5% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $12.1M | 22,000 | 3.0% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $10.2M | 200,000 | 2.5% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $10.1M | 1,079,673 | 2.5% |
| Tectonic Therapeutic Inc(TECX) | COM | 878972108 | $8.8M | 442,056 | 2.1% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $8.6M | 298,123 | 2.1% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $8.0M | 3,517,113 | 1.9% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $7.7M | 479,400 | 1.9% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $7.6M | 539,071 | 1.9% |
| Concentra Group Holdings PAR(CON) | COMMON STOCK | 20603L102 | $6.4M | 312,105 | 1.6% |
| Livanova PLC(LIVN) | SHS | G5509L101 | $6.3M | 140,000 | 1.5% |
| Dexcom Inc(DXCM) | COM | 252131107 | $6.1M | 70,000 | 1.5% |
| Caredx Inc(CDNA) | COM | 14167L103 | $5.9M | 302,808 | 1.4% |
| Select MED Hldgs Corp(SEM) | COM | 81619Q105 | $5.4M | 353,820 | 1.3% |
| Shattuck Labs Inc(STTK) | COM | 82024L103 | $5.3M | 6,638,935 | 1.3% |
| Acadia Healthcare Company in(ACHC) | COM | 00404A109 | $4.8M | 211,816 | 1.2% |
| Corbus Pharmaceuticals Hldgs(CRBP) | COM NEW | 21833P301 | $4.0M | 579,893 | 1.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $3.9M | 1,580,588 | 0.9% |
| Sight Sciences Inc(SGHT) | COM | 82657M105 | $3.6M | 871,687 | 0.9% |
| Axogen Inc(AXGN) | COM | 05463X106 | $3.1M | 282,809 | 0.7% |
| Lantheus Hldgs Inc(LNTH) | COM | 516544103 | $2.8M | 34,576 | 0.7% |
| Mural Oncology PUB LTD Co | ORD SHS | G63365103 | $2.2M | 900,000 | 0.5% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $1.6M | 267,800 | 0.4% |
| Orthopediatrics Corp(KIDS) | COM | 68752L100 | $1.6M | 73,647 | 0.4% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $971.4K | 837,400 | 0.2% |
| Rein Therapeutics Inc(RNTX) | COM NEW | 00887A204 | $599.1K | 427,919 | 0.1% |
| Onkure Therapeutics Inc(OKUR) | COM CL A | 68277Q105 | $381.7K | 159,692 | 0.1% |
| Erasca Inc(ERAS) | COM | 29479A108 | $305.2K | 240,295 | 0.1% |
| Pepgen Inc(PEPG) | COM | 713317105 | $270.8K | 243,980 | 0.1% |